[1] 中国高血压防治指南修订委员会. 中国高血压防治指南2018年修订版(J). 中华心血管病杂志, 2019, 47(2):104-125. [2] 张梅, 吴静, 张笑, 等. 2018 年中国成年居民高血压患病与控制状况研究[ J] . 中华流行病学杂志, 2021, 42( 10): 1780-1789. [3] Feng Y,Kang K,Xue Q,et a1.Value of plasma homo cysteine tO predict stroke,cardiovascular diseases,and new onset hypertension:a retrospective cohort study.Medicine(Baltimore),2020,99:e21541. [4] Guieu R,Ruf J,Motlola G.Hyperhornocysteinemia and cardiovascular diseases.Anil Bi01 Clin(Paris),2022,80 :7-14. [5] Sun N, Mu J, Li Y.Working Committee of Salt evaluation, Blood Pressure Management, Chinese Medical Association Hypertension Professional Committee, Hypertension Group, Chinese Society of Cardiology. An expert recommendation on salt intake and blood pressure management in Chinese patients with hypertension: A statement of the Chinese Medical Association Hypertension Professional Committee[J]. J Clin Hypertens,2019,00:1-5 [6] Zhou MS, Kosaka H, Yoneyama H.Potassium augments vascular relaxation mediated by nitric oxide in the carotid arteries of hypertensive Dahl rats[J]. Am J Hypertens,2000,13:666-72. [7] 王鸿,陈俊宇.原发性高血压与低钾血症的相关性分析[J]. 中国医药指南 ,2014,12(30):13-14. [8] DiBona GF.Neural control of the kidney:past present and futur[J].2003 41:621-624. [9] 吴宁,张红叶.钠钾与高血压病关系的研究进展(J).中国循证心血管医学杂志,2015,7(2):283-285. [10] 邢潇萌,郑刚,H型高血压的临床研究进展(J),医学综述2018,11,24 4400-4403. [11] Pang H,Han B,Fu Q,et al.Association between homocysteine and conventional predisposing factors on risk of stroke in patients with hypertension[J]. Sci Rep,2018,8(1) : 3900. [12] 张三. C1q、Lp-PLA2、ADMA对原发性高血压患者心血管事件发生风险的评估价值(J).河南医学研究,2024,33(24):4506-4510. [13] 徐彩红,冯伟,周福军,等.社区高血压患者进展1年后高同型半胱氨酸血症发生率影响因素情况分析(J).中国乡村医药,2024,31(24):25-27. [14] 柳芳美,廖清池,邓敏.24 h尿钠及血同型半胱氨酸联合检测对高血压性心脏病的诊断价值探讨(J).基层医学论坛,2021,25(04):488-490. [15] 郭钰,朱丽娜,张丽华.原发性高血压患者血清钠钾比及24 h尿钠钾比与血压节律的关系(J).检验医学与临床,2020,17(16):2337-2339,2343. |